Done, a leading direct-to-consumer virtual operator focused on adult ADHD care, is making a bold move to adapt to the rapidly shifting landscape of telehealth regulations. The company has announced the opening of 30 physical clinic locations across the United States—a strategic expansion aimed at blending virtual convenience with in-person care. This shift represents a deliberate move toward an ADHD hybrid care model that prepares Done for looming changes in federal policy.
Navigating New DEA Rules with a Hybrid Approach
The DEA’s proposed rule, released in 2023, would essentially end the telehealth flexibilities that allowed providers to prescribe controlled substances—like many ADHD medications—without in-person visits. While public outcry prompted the DEA to extend these allowances through December 2024, companies like Done are planning ahead. By establishing physical clinics, Done is ensuring its ability to continue providing high-quality ADHD care under a new ADHD hybrid care model.
Expanding Access with Nationwide Clinics
With locations now open in states like California, Texas, New York, Florida, Pennsylvania, Colorado, and 25 others, Done is creating nationwide access points for patients to receive face-to-face care with board-certified clinicians. These in-person visits complement Done’s existing virtual platform, where patients can still complete ADHD self-assessments, get evaluated by licensed providers, and have medications delivered to their homes. The result is a flexible, patient-centered ADHD hybrid care model that balances accessibility with accountability.
Strengthening Safety and Quality Standards
Done’s transition isn’t just about compliance—it’s also about improving care quality. The company incorporates monthly check-ins, biannual treatment reviews, and multi-state Prescription Drug Monitoring Programs (PDMPs) to monitor medication use responsibly. These measures are core to Done’s commitment to ethical prescribing within its ADHD hybrid care model.
Technology-Enhanced Mental Health Treatment
Adding to its toolkit, Done recently launched Future Health, a proprietary digital platform that gives clinicians real-time, data-informed insights to personalize mental health treatment. This innovation aligns with the broader goal of the ADHD hybrid care model: to use both human connection and technology to deliver safe, effective care for adults managing ADHD.
Responding to Industry Scrutiny
Done’s evolution also comes in the wake of increased scrutiny over online prescribing practices. A 2023 Wall Street Journal report suggested the DEA was investigating Done, though the company denied these claims. Meanwhile, other digital health companies—such as Cerebral—have made headlines for facing similar investigations and have even discontinued the prescribing of controlled substances. These industry shifts are pushing many companies to reevaluate their models, and Done’s adoption of an ADHD hybrid care model is one of the more comprehensive responses seen so far.
A New Standard for ADHD Treatment
The shift from virtual-only to hybrid is more than just a regulatory adjustment—it’s a reimagining of how ADHD treatment can and should be delivered. For many adults struggling with ADHD, access to timely and tailored care can significantly improve their quality of life. Done’s nationwide rollout of in-person clinics, combined with its digital infrastructure, demonstrates how an ADHD hybrid care model can meet patient needs today while staying adaptable for tomorrow.
What’s Next for Done?
Founded in 2019, Done was one of the pioneers in virtual ADHD care, serving thousands of patients across the country. Now, as the company moves forward with its ADHD hybrid care model, it continues to build on its mission to make mental health care more accessible, personalized, and clinically sound.
As telehealth rules evolve, Done’s expansion sends a clear message: hybrid care may be the future of mental health treatment. With its growing network of clinics and technology-driven approach, Done’s ADHD hybrid care model is setting a new standard in how we treat and support adults with ADHD.
